NM_170682.4:c.211G>A

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP4_StrongBP6_Very_StrongBS2

The NM_170682.4(P2RX2):​c.211G>A​(p.Glu71Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00266 in 1,612,632 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 12 hom. )

Consequence

P2RX2
NM_170682.4 missense

Scores

5
9
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.18

Publications

10 publications found
Variant links:
Genes affected
P2RX2 (HGNC:15459): (purinergic receptor P2X 2) The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]
P2RX2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 41
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 6: AlphaMissense, Cadd, Dann, FATHMM_MKL, M_CAP, PrimateAI [when BayesDel_addAF, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.028756559).
BP6
Variant 12-132619476-G-A is Benign according to our data. Variant chr12-132619476-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 229124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 230 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
P2RX2NM_170682.4 linkc.211G>A p.Glu71Lys missense_variant Exon 2 of 11 ENST00000643471.2 NP_733782.1 Q9UBL9-1Q32MC3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
P2RX2ENST00000643471.2 linkc.211G>A p.Glu71Lys missense_variant Exon 2 of 11 NM_170682.4 ENSP00000494644.1 Q9UBL9-1

Frequencies

GnomAD3 genomes
AF:
0.00151
AC:
230
AN:
152022
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000604
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00263
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00156
AC:
390
AN:
249322
AF XY:
0.00155
show subpopulations
Gnomad AFR exome
AF:
0.000310
Gnomad AMR exome
AF:
0.00133
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000785
Gnomad NFE exome
AF:
0.00271
Gnomad OTH exome
AF:
0.00295
GnomAD4 exome
AF:
0.00278
AC:
4057
AN:
1460498
Hom.:
12
Cov.:
33
AF XY:
0.00263
AC XY:
1914
AN XY:
726634
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33450
American (AMR)
AF:
0.00168
AC:
75
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86254
European-Finnish (FIN)
AF:
0.000758
AC:
40
AN:
52768
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00339
AC:
3766
AN:
1111482
Other (OTH)
AF:
0.00270
AC:
163
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
207
414
620
827
1034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00151
AC:
230
AN:
152134
Hom.:
0
Cov.:
32
AF XY:
0.00136
AC XY:
101
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41520
American (AMR)
AF:
0.000850
AC:
13
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00263
AC:
179
AN:
67960
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00235
Hom.:
1
Bravo
AF:
0.00148
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00149
AC:
181
Asia WGS
AF:
0.000289
AC:
1
AN:
3474
EpiCase
AF:
0.00327
EpiControl
AF:
0.00261

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

P2RX2: BS1, BS2 -

not specified Benign:1
Jan 24, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Glu71Lys in exon 2 of P2RX2: This variant is not expected to have clinical sig nificance because it has been identified in 0.3% (334/125162) of European chromo somes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.o rg; dbSNP rs143664462). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.44
T;T;.;.;.;.;T
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
.;D;D;D;D;D;D
M_CAP
Pathogenic
0.79
D
MetaRNN
Benign
0.029
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
4.2
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-2.5
.;D;D;D;D;D;.
REVEL
Uncertain
0.41
Sift
Uncertain
0.0020
.;D;D;D;D;D;.
Sift4G
Uncertain
0.0070
.;D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D;D
Vest4
0.59, 0.25, 0.52, 0.56, 0.53
MVP
0.63
MPC
2.0
ClinPred
0.070
T
GERP RS
4.4
Varity_R
0.71
gMVP
0.84
Mutation Taster
=29/71
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143664462; hg19: chr12-133196062; COSMIC: COSV100268803; COSMIC: COSV100268803; API